The eumelanin versus pheomelanin distinction is one of the most biologically important aspects of melanin biology, and research on MT-1 effects on the balance between these two melanin forms connects the MC1R signaling pharmacology covered in the Melanotan I research cluster to the photoprotection and pigmentation endpoints that define the research applications of the compound.
Melanotan I Eumelanin vs Pheomelanin Research: Tyrosinase Pathway Studies
Melanotan I · Published April 14, 2026 · Updated May 18, 2026 · 7 min read
Quick Answer
Melanotan I eumelanin vs pheomelanin research examines the balance between brown/black eumelanin and yellow/red pheomelanin pigments through tyrosinase pathway activation. Studies measure HPLC-quantified pigment ratios, melanogenic enzyme expression, and pigment composition shifts in cellular and rodent melanocyte research models. For research use only, not for human consumption.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
- The Two Melanin Forms
- The Tyrosinase Pathway Branch Point
- MT-1 and the Eumelanin Shift
- Photoprotective Consequences
- Research Methods for Eumelanin and Pheomelanin Quantification
- Relationship to MT-2 Pharmacology
- Genetic Variation Context
- Research Peptide Referenced
- Related Research Reading
- Related Research Articles
- Explore Related Products
- Frequently Asked Questions
- Glossary
Frequently Asked Questions
What is Melanotan I in research contexts?
+
Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with high MC1R selectivity. It is studied in preclinical research and clinical literature for melanogenesis, photoprotection, and erythropoietic protoporphyria.
What is the difference between eumelanin and pheomelanin?
+
Eumelanin is the dark brown to black, photoprotective melanin that absorbs UV radiation effectively. Pheomelanin is the red to yellow melanin that provides limited photoprotection and may generate damaging reactive species under UV exposure. The eumelanin/pheomelanin ratio is regulated by MC1R signaling.
How does Melanotan I shift the eumelanin/pheomelanin balance?
+
MC1R activation by Melanotan I directs the tyrosinase pathway toward eumelanin synthesis at the expense of pheomelanin, producing a darker, more photoprotective melanin profile in research models. The cysteine availability also influences the eumelanin/pheomelanin balance.
Is Melanotan I approved for human use?
+
Glossary
Key terms used in this article.
- MC1R
- Melanocortin 1 receptor, the primary GPCR on melanocytes that signals melanin synthesis upon alpha-MSH binding.
- Melanogenesis
- The biochemical pathway producing melanin from tyrosine within melanosomes of melanocytes.
- Eumelanin
- The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
- Tyrosinase
- The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.
- Erythropoietic Protoporphyria (EPP)
- A rare genetic disorder of heme biosynthesis causing severe photosensitivity, the indication for clinical afamelanotide use.
- Pheomelanin
- The red to yellow melanin pigment with limited photoprotection, predominant in MC1R variants associated with red hair.
More from the Blog
Continue exploring research insights and updates.
Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.
